Veytics Intelligence
2026-11-13 · NASDAQ

Appili Therapeutics Q2 Sales Decline

(RTTNews) - Appili Therapeutics (APLIF) released Loss for second quarter of -C$1.84 million

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.